{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1048.17","meta":{"versionId":"4","lastUpdated":"2022-03-02T18:05:07.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Telligen Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1048.17","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1048.17"}],"version":"20160205","name":"IMM2IntoleranceToInfluenzaVaccine","title":"IMM2 Intolerance to Influenza Vaccine","status":"active","experimental":false,"date":"2022-03-03T18:46:01-05:00","publisher":"Telligen","description":"Grouping value set","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Under Development),(Data Element Scope: Under Development),(Inclusion Criteria: Under Development),(Exclusion Criteria: Under Development)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1048.13"]}]},"expansion":{"identifier":"urn:uuid:cb1d1d04-63a4-4c7e-9816-bac6c8981ed5","timestamp":"2023-12-10T20:56:56-05:00","total":1,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"420113004","display":"Adverse reaction to component of vaccine product containing Influenza virus antigen (disorder)"}]}}